Live Breaking News & Updates on Calliditas Therapeutics Ab Publ |Page 5

Stay updated with breaking news from Calliditas therapeutics ab publ . Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Calliditas Therapeutics AB (publ) (NASDAQ:CALT) Price Target Cut to $18.00

Calliditas Therapeutics AB (publ) (NASDAQ:CALT – Get Free Report) had its target price decreased by analysts at Guggenheim from $21.00 to $18.00 in a report released on Friday, FlyOnTheWall reports. Guggenheim’s price objective would suggest a potential upside of 8.17% from the company’s current price. Separately, HC Wainwright initiated coverage on shares of Calliditas Therapeutics […] ....

Sorce Advisory , Deutsche Bank , Tower Research Capital , Company Profile , Ironwood Investment Management , Calliditas Therapeutics , Get Free Report , Research Capital , Street Group , Investment Management , Calliditas Therapeutics Ab Publ , Nasdaq Calt , Lower Price Target ,

Calliditas Therapeutics AB (publ) (NASDAQ:CALT) Shares Gap Up to $15.90

Calliditas Therapeutics AB (publ) (NASDAQ:CALT – Get Free Report) gapped up before the market opened on Friday . The stock had previously closed at $15.90, but opened at $16.64. Calliditas Therapeutics AB (publ) shares last traded at $16.86, with a volume of 19,324 shares changing hands. Analyst Ratings Changes A number of research firms have […] ....

Company Profile , Sorce Advisory , Tower Research Capital , Deutsche Bank , Ironwood Investment Management , Calliditas Therapeutics , Get Free Report , Research Capital , Street Group , Investment Management , Calliditas Therapeutics Ab Publ , Nasdaq Calt ,

Calliditas Therapeutics AB (publ) (NASDAQ:CALT) Sees Significant Decline in Short Interest

Calliditas Therapeutics AB (publ) (NASDAQ:CALT – Get Free Report) saw a significant drop in short interest in the month of July. As of July 31st, there was short interest totalling 1,900 shares, a drop of 24.0% from the July 15th total of 2,500 shares. Based on an average daily volume of 6,900 shares, the days-to-cover […] ....

Ironwood Investment Management , Tower Research Capital , Deutsche Bank , Sorce Advisory , Company Profile , Calliditas Therapeutics , Get Free Report , Research Capital , Street Group , Investment Management , Calliditas Therapeutics Ab Publ , Nasdaq Calt ,

Calliditas Therapeutics AB (publ) (NASDAQ:CALT) Sees Significant Decrease in Short Interest

Calliditas Therapeutics AB (publ) (NASDAQ:CALT – Get Free Report) was the recipient of a large drop in short interest in the month of July. As of July 31st, there was short interest totalling 1,900 shares, a drop of 24.0% from the July 15th total of 2,500 shares. Based on an average daily trading volume, of […] ....

Tower Research Capital , Deutsche Bank , Sorce Advisory , Ironwood Investment Management , Company Profile , Calliditas Therapeutics , Get Free Report , Street Group , Research Capital , Investment Management , Calliditas Therapeutics Ab Publ , Nasdaq Calt ,

Calliditas Therapeutics AB (publ) (NASDAQ:CALT) Sees Large Growth in Short Interest

Calliditas Therapeutics AB (publ) (NASDAQ:CALT – Get Rating) saw a large increase in short interest during the month of May. As of May 31st, there was short interest totalling 8,400 shares, an increase of 47.4% from the May 15th total of 5,700 shares. Based on an average daily volume of 11,000 shares, the short-interest ratio […] ....

Deutsche Bank , Sorce Advisory , Ironwood Investment Management , Optiver Holding , Calliditas Therapeutics , Get Rating , Investment Management , Street Group , Calliditas Therapeutics Ab Publ , Nasdaq Calt ,